Document is current

Article History

Received: 9 May 2025

Accepted: 21 July 2025

First Online: 17 December 2025

Competing interests

: J.M. receives royalties for books about psychiatric drugs and was a co-applicant on the REDUCE trial, funded by the National Institute of Health Research (NIHR), evaluating digital support for patients stopping long-term antidepressant treatment. M.A.H. and J.M. are both co-applicants on the RELEASE and RELEASE+ trials in Australia, funded by the Medical Research Future Fund (MRFF) and the National Health and Medical Research Council (NHMRC), evaluating hyperbolic tapering of antidepressants against care as usual. M.A.H. reports being a co-founder of and consultant to Outro Health, a digital clinic which provides support for patients in the US to help stop no longer needed antidepressant treatment using gradual, hyperbolic tapering. M.A.H. receives royalties for the Maudsley Deprescribing Guidelines.